McKesson (MCK) Awarded $2.61B U.S. Defense Contract
McKesson Corp. (NYSE: MCK) said to have been awarded a U.S. defense contract covering mail order pharmaceutical delivery. The maximum value of the award is $2.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alnylam Pharma (ALNY) Announces Positive Fitusiran Phase 1 Data as Hemophilia and Rare Bleeding Disorders Treatment
- Caterpillar (CAT) Reports 12% Decline in June Machine Sales
- Tobira Therapeutics (TBRA) Announces Cenicriviroc Phase 2b Missed Primary Endpoint
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!